m625 is not a clinical decision tool · not a publisher · not an expert authority · not a simulator. It is a cross-domain Roll-formalized evidence atlas with public audit + attack surface.
Why a neurodegen-focused clinician would come to evidence.x1000.ai
A clinician treating neurodegenerative conditions (Alzheimer's spectrum / Parkinson's spectrum / mixed dementia) needs cross-period trajectory framing that does not slide into individual prediction. Pain points:
the 5-year vs 15-year cross-period frame is the practical evidence horizon;
biomarker-based vs symptom-based intervention boundaries (Δ_B) need formal separation;
patient-family communication is high-stakes — the cure / reverse lexicon is everywhere and grounded evidence framing is rare.
m625 does not advise on specific neurodegen care. **m625 shows what a `K4.1 = (1, 0, 0)`-style cross-period Roll-formalized object looks like** (visible X biomarker change, Φ dynamics not visibly altered, no `Δ_B` intervention boundary altered) — the typical *progression* claim, formalized without sliding into individual prediction.
This is not a clinical decision directive tool. This is not an individual-patient prognosis. (See "What this demo will not say".)
The Roll-formalized object (anchored on m620 02_exec_004_NEURODEGEN)
Field
Value
Upstream verification
m620 02_exec_004_NEURODEGEN (L1 disk W0 pre-flight 2026-05-22)
m625 does not modify m620 exec dirs. Researchers requesting cross-disease verification do so via 06_registry/outbound_to_m620/.
How a clinician should read this evidence (≤ 5 minutes)
Population-level biomarker-progression pattern.K4.1 = (1, 0, 0) declares: biomarker substrate X is visibly altered (b_X = 1), Φ dynamics is not visibly altered (b_phi = 0), intervention boundary is not visibly altered (b_delta_B = 0). This is the progression-without-intervention pattern at the population level.
The 5-year vs 15-year frame. When a clinician reads a neurodegen evidence paper, the first question to ask is: what cross-period horizon does this paper claim K4.1 closure over? A paper that does not declare its horizon has by definition not satisfied m610 F5 (cross-period K4.1 declaration).
What this does NOT tell a clinician. It does not specify an intervention for any given patient. It does not assert that any given patient will progress at a specific rate (this patient will is the NCNU P_3 forbidden form). It does not classify any patient by Roll subtype. (NCNU P_1 + P_3 inheritance.)
Cross-disease caveat. Alzheimer's / Parkinson's / mixed dementia share the Roll machinery (TMU-B form), but the substantive biology (amyloid+tau vs alpha-synuclein) differs. transferability_pct: necessary-but-not-sufficient per W6.3.
What this demo will not say (anti-drift)
❌ It does not promise reversal of neurodegen, restoration of cognition, or rejuvenation (cure / reverse lexicon).
❌ It does not predict any individual patient's trajectory (NCNU P_3).
❌ It does not recommend any specific intervention or drug class (NCNU P_1).
❌ It does not affirm or vouch for any expert, clinic, or sponsor (m517 W7-N inheritance).
❌ It does not run revolutionary / breakthrough / state-of-the-art marketing lexicon.
Falsifying prediction
The K4.1 = (1, 0, 0) progression-without-intervention framing would be falsified by:
m620 02_exec_004_NEURODEGEN verdict that shows the biomarker-trajectory data fits K4.1 = (1, 1, 0) (Φ dynamics also altered) better than K4.1 = (1, 0, 0); OR
cross-disease replication failing — i.e., an Alzheimer's spectrum cooked case yields a substantively different K4.1 bit pattern than a Parkinson's spectrum one when both go through the same audit pipeline.
Attack surface entries
AS-001 (cure / reverse neurodegen lexicon) — G2.2
AS-003 (individual prediction for an at-risk patient) — G2.4 NCNU P_3 + m610 S2
待办: actual m620 verdict on 02_exec_004_NEURODEGEN ingestion · per-disease (Alzheimer's vs Parkinson's vs mixed) sub-cases (v0.4+).
漏洞: K4.1 = (1, 0, 0) is the m625-proposed reading of m620's exec dir; m620 verdict is open. Cross-disease replication is asserted as necessary-but-not-sufficient; substantive replication is m620/m590 sovereign work.
反驳预案:
- *"5-year frame is too short for Alzheimer's."* — Yes for natural-history; not for biomarker-trajectory milestones. The horizon declaration (per F5) is what's mandatory; the choice of horizon is per-claim.
- *"`(1, 0, 0)` ignores intervention."* — Correct: this is the progression-without-intervention pattern. Intervention-active claims would carry `K4.1 = (1, 1, 1)` or `(1, 0, 1)` depending on Φ alteration · those are separate cooked objects.